{
  "id": "SCR-LIP-000440",
  "statement": "In 40 lipedema patients, dual-energy X-ray absorptiometry was used to measure total and mean lower extremity fat mass and extremity volumes, but no difference in these measures was found between patients with high versus low kinesiophobia.",
  "statement_pt": "Em 40 pacientes com lipedema, a absorciometria de raios-X de dupla energia foi utilizada para medir a massa gorda total e média das extremidades inferiores e os volumes das extremidades, mas não houve diferença nessas medidas entre pacientes com cinesiofobia alta versus baixa.",
  "claim_type": "clinical_association",
  "context": {
    "population": "40 women with lipedema and 40 controls",
    "condition": "lipedema",
    "exposure": "DXA measurement of lower extremity fat mass and volume",
    "comparator": "lipedema patients with high vs low kinesiophobia",
    "outcome": "lower extremity fat mass and extremity volumes",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "title": "Unveiling kinesiophobia: A hidden challenge",
      "ref": "DOI:10.1177/02683555251360606",
      "stance": "context",
      "study_design": "case_control",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "the lipedema patients were evaluated in terms of extremity volumes, and total and mean lower extremity fat mass by dualenergy X-ray absorptiometry",
      "extraction_confidence": "high",
      "note": "DXA is used to measure lower extremity fat mass in lipedema patients, but the abstract does not test whether DXA identifies a lipedema-specific fat distribution pattern; it only uses DXA as a measurement tool within a kinesiophobia study, m",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article confirms DXA was used to measure total and mean lower extremity fat mass in 40 lipedema patients, and explicitly states no difference was found between high and low kinesiophobia groups in fat mass or extremity volumes. The stat",
        "date": "2026-09-20"
      }
    }
  ],
  "relations": [],
  "gaps": "Auto-ingested single source; not yet human-reviewed.",
  "primary_amato_source": null,
  "curators": [],
  "provenance": {
    "auto": true,
    "engine": "anthropic/claude-opus-4.8",
    "question": "SQ-LIP-000031",
    "source": "library",
    "ingested": "2026-09-20"
  },
  "created": "2026-09-20",
  "updated": "2026-09-20",
  "history": [
    {
      "date": "2026-09-20",
      "event": "created",
      "detail": "auto-ingested for SQ-LIP-000031"
    }
  ],
  "license": "CC-BY-4.0",
  "answers_questions": [
    {
      "id": "SQ-LIP-000031",
      "role": "context",
      "question": "Can DXA (dual-energy X-ray absorptiometry) help identify lipedema fat distribution?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000031.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000440.html"
}